Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

Conclusions. A significant number of patients are at risk for DDIs if treated with the recently approved DAA regimens. A careful evaluation of potential DDI is essential to prevent adverse effects or unnecessary risk of treatment failure.

Source: Clinical Infectious Diseases - February 4, 2016 Category: Infectious Diseases Authors: Höner zu Siederdissen, C., Maasoumy, B., Marra, F., Deterding, K., Port, K., Manns, M. P., Cornberg, M., Back, D., Wedemeyer, H. Tags: ARTICLES AND COMMENTARIES Source Type: research